These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 30203400)

  • 21. In vivo expression of insulin-like growth factor-binding protein-2 in human gliomas increases with the tumor grade.
    Elmlinger MW; Deininger MH; Schuett BS; Meyermann R; Duffner F; Grote EH; Ranke MB
    Endocrinology; 2001 Apr; 142(4):1652-8. PubMed ID: 11250947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma.
    Pang C; Guan Y; Zhao K; Chen L; Bao Y; Cui R; Li G; Wang Y
    Int J Clin Exp Pathol; 2015; 8(5):4943-52. PubMed ID: 26191187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Relationship of bcl-2 gene expression with cell proliferation and apoptosis in human gliomas].
    Yu S; Pu P; Jiang D; An T; Guan X; Yang L
    Zhonghua Bing Li Xue Za Zhi; 2000 Feb; 29(1):12-5. PubMed ID: 11866884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ccl5 establishes an autocrine high-grade glioma growth regulatory circuit critical for mesenchymal glioblastoma survival.
    Pan Y; Smithson LJ; Ma Y; Hambardzumyan D; Gutmann DH
    Oncotarget; 2017 May; 8(20):32977-32989. PubMed ID: 28380429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased expression of SOX9 indicates a better prognosis and inhibits the growth of glioma cells by inducing cell cycle arrest.
    Gao J; Zhang JY; Li YH; Ren F
    Int J Clin Exp Pathol; 2015; 8(9):10130-8. PubMed ID: 26617720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-675 promotes glioma cell proliferation and motility by negatively regulating retinoblastoma 1.
    Zheng Y; Lu X; Xu L; Chen Z; Li Q; Yuan J
    Hum Pathol; 2017 Nov; 69():63-71. PubMed ID: 28970140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fos-related antigen 1 modulates malignant features of glioma cells.
    Debinski W; Gibo DM
    Mol Cancer Res; 2005 Apr; 3(4):237-49. PubMed ID: 15831677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RIP2 promotes glioma cell growth by regulating TRAF3 and activating the NF‑κB and p38 signaling pathways.
    Cai X; Yang Y; Xia W; Kong H; Wang M; Fu W; Long M; Hu Y; Xu D
    Oncol Rep; 2018 Jun; 39(6):2915-2923. PubMed ID: 29693188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Downregulation of TES by hypermethylation in glioblastoma reduces cell apoptosis and predicts poor clinical outcome.
    Bai Y; Zhang QG; Wang XH
    Eur J Med Res; 2014 Dec; 19(1):66. PubMed ID: 25498217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of Runx2 in IGF-1Rβ/Akt- and AMPK/Erk-dependent growth, survival and sensitivity towards metformin in breast cancer bone metastasis.
    Tandon M; Chen Z; Othman AH; Pratap J
    Oncogene; 2016 Sep; 35(36):4730-40. PubMed ID: 26804175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oncostatin-M differentially regulates mesenchymal and proneural signature genes in gliomas via STAT3 signaling.
    Natesh K; Bhosale D; Desai A; Chandrika G; Pujari R; Jagtap J; Chugh A; Ranade D; Shastry P
    Neoplasia; 2015 Feb; 17(2):225-37. PubMed ID: 25748242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of tibolone on the human primary glioblastoma multiforme cell culture and the rat C6 glioma model.
    Altinoz MA; Albayrak SB; Karasu A; Sabanci PA; Imer M; Bilir A
    Neurol Res; 2009 Nov; 31(9):923-7. PubMed ID: 19531283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Temozolomide inhibits cellular growth and motility via targeting ERK signaling in glioma C6 cells.
    Wang Y; Gao S; Wang W; Liang J
    Mol Med Rep; 2016 Dec; 14(6):5732-5738. PubMed ID: 27878252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcriptional regulation of Runx2 by HSP90 controls osteosarcoma apoptosis via the AKT/GSK-3β/β-catenin signaling.
    Liang GH; Liu N; He MT; Yang J; Liang ZJ; Gao XJ; Rahhal AH; He QY; Zhang HT; Zha ZG
    J Cell Biochem; 2018 Jan; 119(1):948-959. PubMed ID: 28681940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DSE promotes aggressive glioma cell phenotypes by enhancing HB-EGF/ErbB signaling.
    Liao WC; Liao CK; Tsai YH; Tseng TJ; Chuang LC; Lan CT; Chang HM; Liu CH
    PLoS One; 2018; 13(6):e0198364. PubMed ID: 29864158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting of Runx2 by miR-135 and miR-203 Impairs Progression of Breast Cancer and Metastatic Bone Disease.
    Taipaleenmäki H; Browne G; Akech J; Zustin J; van Wijnen AJ; Stein JL; Hesse E; Stein GS; Lian JB
    Cancer Res; 2015 Apr; 75(7):1433-44. PubMed ID: 25634212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduction of CD200 expression in glioma cells enhances microglia activation and tumor growth.
    Wang CY; Hsieh YT; Fang KM; Yang CS; Tzeng SF
    J Neurosci Res; 2016 Dec; 94(12):1460-1471. PubMed ID: 27629530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-146b-5p functions as a tumor suppressor by targeting TRAF6 and predicts the prognosis of human gliomas.
    Liu J; Xu J; Li H; Sun C; Yu L; Li Y; Shi C; Zhou X; Bian X; Ping Y; Wen Y; Zhao S; Xu H; Ren L; An T; Wang Q; Yu S
    Oncotarget; 2015 Oct; 6(30):29129-42. PubMed ID: 26320176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional analysis of the DEPDC1 oncoantigen in malignant glioma and brain tumor initiating cells.
    Kikuchi R; Sampetrean O; Saya H; Yoshida K; Toda M
    J Neurooncol; 2017 Jun; 133(2):297-307. PubMed ID: 28555424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endothelin B receptor promotes the proliferation and immune escape of malignant gliomas.
    Pan DS; Feng SZ; Cao P; Li JJ
    Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1230-1235. PubMed ID: 28841806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.